marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
BioMarin Pharmaceutical Financial Ratios 2011-2024 | BMRN
Annual Financial Ratios BioMarin Pharmaceutical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
100.8 | 134.6 | -252.1 | 18.6 | -639.6 | -222.4 | -134.3 | -22.5 | -68.9 | -106.1 | -54.3 | -57.0 | -74.1 |
P/S |
7.0 | 9.1 | 8.8 | 8.5 | 9.0 | 11.5 | 12.0 | 12.7 | 13.3 | 18.9 | 17.5 | 13.0 | 9.0 |
EPS |
0.9 | 0.8 | -0.3 | 4.7 | -0.1 | -0.4 | -0.7 | -3.8 | -1.1 | -0.9 | -1.3 | -0.9 | -0.5 |
EV (Enterprise Value) |
18 B | 20.1 B | 17.3 B | 16.9 B | 16.4 B | 18.1 B | 16.9 B | 15 B | 12.8 B | 14.3 B | 9.92 B | 6.92 B | 4.48 B |
EBITDA per Share |
1.4 | 1.36 | 0.14 | 0.34 | -0.287 | -0.704 | -0.534 | -1.39 | -1.87 | -0.973 | -0.997 | -0.761 | -0.29 |
EV/EBITDA |
670.7 | -531.8 | -305.1 | -140.3 | -174.8 | -62.6 | -40.5 | -98.3 | -70.4 | -73.0 | -132.3 | ||
PEG |
0.94 | 1.19 | 3.44 | -0.28 | -9.11 | -6.37 | -1.63 | 0.09 | 4.23 | -3.77 | 1.56 | 0.58 | 0.6 |
P/B |
3.4 | 4.1 | 3.8 | 3.9 | 4.9 | 5.8 | 5.6 | 5.1 | 4.9 | 9.3 | 7.1 | 6.4 | 5.2 |
P/CF |
106.1 | 108.3 | 53.0 | 185.7 | -132.5 | -138.0 | -75.6 | -37.7 | -26.4 | -73.9 | -76.8 | -241.6 | -29.5 |
ROE % |
3.39 | 3.08 | -1.50 | 20.83 | -0.76 | -2.60 | -4.17 | -22.78 | -7.16 | -8.77 | -13.15 | -11.26 | -6.96 |
ROA % |
2.45 | 2.22 | -1.07 | 14.60 | -0.51 | -1.74 | -2.53 | -15.66 | -4.61 | -5.38 | -7.84 | -7.14 | -4.13 |
ROCE % |
3.19 | 3.25 | -1.93 | -1.06 | -3.34 | -4.44 | -3.66 | -5.70 | -8.57 | -7.11 | -7.55 | -7.70 | -2.80 |
Current Ratio |
3.6 | 3.6 | 3.5 | 3.4 | 2.1 | 3.9 | 2.7 | 3.2 | 2.4 | 6.0 | 6.2 | 4.4 | 5.0 |
DSO |
82.6 | 72.7 | 81.2 | 81.0 | 80.8 | 83.9 | 72.6 | 70.4 | 73.5 | 97.8 | 78.4 | 79.5 | 91.7 |
DIO |
709.4 | 630.4 | 572.2 | 480.0 | 690.7 | 614.6 | 718.2 | 618.4 | 652.4 | 561.0 | 619.9 | 511.5 | 565.2 |
DPO |
- | - | - | - | 244.7 | 240.4 | 251.5 | 333.2 | 430.5 | 369.2 | 363.3 | 266.9 | 53.2 |
Operating Cycle |
792.0 | 703.1 | 653.4 | 561.0 | 771.6 | 698.5 | 790.9 | 688.7 | 725.8 | 658.8 | 698.3 | 591.0 | 657.0 |
Cash Conversion Cycle |
792.0 | 703.1 | 653.4 | 561.0 | 526.9 | 458.1 | 539.3 | 355.5 | 295.3 | 289.5 | 335.0 | 324.1 | 603.8 |
All numbers in USD currency
Quarterly Financial Ratios BioMarin Pharmaceutical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.56 | 0.56 | 0.47 | - | 0.21 | 0.3 | 0.27 | - | -0.04 | 0.15 | 0.66 | - | -0.2 | 0.07 | 0.1 | - | 4.33 | -0.16 | 0.45 | - | 0.31 | -0.21 | -0.32 | - | -0.07 | -0.09 | -0.25 | - | -0.07 | -0.21 | -0.09 | - | -0.22 | -2.58 | -0.51 | - | -0.57 | -0.51 | -0.43 | - | 0.05 | -0.23 | -0.26 | - | -0.38 | -0.15 | -0.31 | - | -0.04 | -0.27 | -0.21 | - | -0.16 | -0.05 | -0.04 |
EBITDA per Share |
0.66 | 0.69 | 0.61 | - | 0.21 | 0.4 | 0.48 | - | 0.03 | 0.26 | 0.89 | - | 0.16 | 0.13 | 0.29 | - | 0.12 | 0.06 | 0.73 | - | 0.47 | 0.04 | -0.18 | - | 0.31 | 0.11 | -0.12 | - | 0.26 | - | - | - | 0.1 | -3.23 | -0.38 | - | -0.3 | -0.26 | -0.35 | - | 0.35 | 0.05 | -0.1 | - | -0.09 | 0.03 | -0.17 | - | 0.19 | -0.08 | -0.1 | - | 0.1 | 0.16 | 0.1 |
ROE % |
6.56 | 5.42 | 4.57 | 3.09 | 2.94 | 1.97 | 1.42 | 3.22 | 2.37 | 1.66 | 1.35 | -0.13 | 18.98 | 38.95 | 37.93 | 20.38 | 22.15 | 4.80 | 4.31 | -1.24 | -1.67 | -3.86 | -3.22 | -2.48 | -2.92 | -2.95 | -3.69 | -2.34 | -3.69 | -4.60 | -18.43 | -19.50 | -23.29 | -25.72 | -13.99 | -10.01 | -9.53 | -5.25 | -4.03 | -4.20 | -8.15 | -12.59 | -12.01 | -8.53 | -9.06 | -5.63 | -7.17 | -6.04 | -8.32 | -10.08 | -7.58 | -3.51 | -2.28 | -0.66 | -0.57 |
ROA % |
4.95 | 4.00 | 3.34 | 2.24 | 2.14 | 1.43 | 2.57 | 3.88 | 3.27 | 0.77 | 0.99 | -0.09 | 13.33 | 27.36 | 26.64 | 14.31 | 15.49 | 3.24 | 2.94 | -0.83 | -1.11 | -2.57 | -2.15 | -1.66 | -1.93 | -1.92 | -2.33 | -1.42 | -2.35 | -3.01 | -12.63 | -13.41 | -15.85 | -17.35 | -9.14 | -6.45 | -6.15 | -3.41 | -2.56 | -2.58 | -4.94 | -7.60 | -7.22 | -5.10 | -5.43 | -3.40 | -4.44 | -3.83 | -5.18 | -6.20 | -4.59 | -2.08 | -1.35 | -0.39 | -0.34 |
ROCE % |
6.75 | 5.27 | 4.36 | 3.33 | 3.28 | 2.60 | 2.10 | 3.95 | 2.70 | 1.50 | 0.91 | -0.37 | -1.73 | -1.85 | -3.12 | 0.20 | 0.33 | 1.82 | 1.49 | -2.92 | -3.45 | -4.11 | -3.64 | -2.88 | -3.37 | -3.32 | -3.85 | -2.59 | -4.76 | -6.45 | -25.77 | -25.80 | -29.21 | -30.45 | -12.42 | -8.83 | -8.10 | -3.95 | -2.51 | -2.23 | -6.02 | -10.53 | -10.79 | -7.73 | -8.77 | -6.02 | -7.57 | -6.23 | -8.24 | -9.21 | -6.07 | -1.61 | -2.01 | 0.10 | 0.30 |
Current Ratio |
4.8 | 4.0 | 3.8 | 3.6 | 3.6 | 3.7 | 3.6 | 3.6 | 3.7 | - | 3.6 | 3.5 | 3.5 | 3.6 | 3.5 | 3.4 | 3.4 | 3.4 | 3.4 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 2.5 | 2.5 | 2.5 | 2.5 | 3.2 | 3.2 | 3.2 | 3.2 | 2.8 | 2.8 | 2.8 | 2.8 | 2.6 | 2.6 | 2.6 | 2.6 | 2.5 | 2.5 | 2.5 | 2.5 | 2.8 | 2.7 | 2.7 | 2.7 | 2.5 | 2.5 | 2.5 | 2.5 |
DSO |
89.9 | 85.1 | 89.4 | - | 92.8 | 92.6 | 81.0 | - | 37.9 | 36.8 | 70.6 | - | 89.2 | 74.6 | 79.3 | - | 85.8 | 95.3 | 75.0 | - | 74.7 | 88.8 | 82.0 | - | 79.8 | 83.9 | 73.8 | - | 71.4 | 75.1 | 71.6 | - | 70.2 | 65.5 | 73.3 | - | 72.0 | 60.2 | 69.6 | - | 74.7 | 68.7 | 79.0 | - | 78.5 | 78.6 | 80.9 | - | 77.7 | 80.2 | 83.7 | - | 84.3 | 86.5 | - |
DIO |
572.1 | 811.9 | 818.3 | - | 715.4 | 661.7 | 610.6 | - | 329.4 | 291.4 | 609.7 | - | 643.5 | 511.6 | 536.3 | - | 337.6 | 650.6 | 564.8 | - | 640.3 | 801.6 | 619.6 | - | 614.0 | 613.0 | 557.8 | - | 729.9 | 771.1 | 758.1 | - | 638.7 | 627.8 | 663.2 | - | 710.3 | 651.3 | 693.5 | - | 608.3 | 583.1 | 724.0 | - | 528.9 | 657.5 | 648.3 | - | 477.0 | 498.1 | 690.3 | - | 529.0 | 616.4 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.2 | 59.6 | 83.0 | - | 90.6 | 79.7 | 139.3 | - | 120.0 | 149.2 | 135.5 | - | 88.9 | 92.9 | 96.6 | - | 49.8 | 58.0 | - |
Operating Cycle |
661.9 | 897.0 | 907.7 | - | 808.2 | 754.3 | 691.6 | - | 367.2 | 328.2 | 680.3 | - | 732.8 | 586.3 | 615.6 | - | 423.4 | 745.9 | 639.9 | - | 715.0 | 890.4 | 701.6 | - | 693.8 | 696.9 | 631.6 | - | 801.3 | 846.2 | 829.7 | - | 708.9 | 693.2 | 736.5 | - | 782.3 | 711.5 | 763.0 | - | 683.0 | 651.9 | 803.0 | - | 607.5 | 736.1 | 729.2 | - | 554.7 | 578.4 | 774.0 | - | 613.3 | 702.9 | - |
Cash Conversion Cycle |
661.9 | 897.0 | 907.7 | - | 808.2 | 754.3 | 691.6 | - | 367.2 | 328.2 | 680.3 | - | 732.8 | 586.3 | 615.6 | - | 423.4 | 745.9 | 639.9 | - | 715.0 | 890.4 | 701.6 | - | 693.8 | 696.9 | 631.6 | - | 801.3 | 846.2 | 829.7 | - | 708.9 | 693.2 | 736.5 | - | 748.1 | 651.9 | 680.0 | - | 592.4 | 572.2 | 663.6 | - | 487.4 | 586.9 | 593.7 | - | 465.8 | 485.5 | 677.4 | - | 563.6 | 644.9 | - |
All numbers in USD currency